118 participants
Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-09-16
- Start Date:
- 2025-09-08
- Completion:
- 2028-10-01
Conditions
- Non-Small Cell Lung Cancer
- EGFR
Interventions
- PROCEDURE
- DRUG
No Results Yet